部位 | ICD-O-3 | 合計 | 男性 | 女性 | |||
---|---|---|---|---|---|---|---|
件数 | % | 件数 | % | 件数 | % | ||
全部位 | 3,035 | 100.0% | 1,730 | 100.0% | 1,305 | 100.0% | |
頭頸部 | C00-C14 C30-C32 | 233 | 7.7% | 157 | 9.1% | 76 | 5.8% |
食道 | C15 | 208 | 6.9% | 173 | 10.0% | 35 | 2.7% |
胃 | C16 | 228 | 7.5% | 181 | 10.5% | 47 | 3.6% |
大腸 | C18-C21 | 241 | 7.9% | 141 | 8.2% | 100 | 7.7% |
( 結腸 ) | C18 | 163 | 5.4% | 87 | 5.0% | 76 | 5.8% |
( 直腸S状結腸移行部、直腸 、肛門及び肛門管 ) | C19-C21 | 78 | 2.6% | 54 | 3.1% | 24 | 1.8% |
膵 | C25 | 136 | 4.5% | 85 | 4.9% | 51 | 3.9% |
気管、気管支及び肺 | C33-C34 | 232 | 7.6% | 157 | 9.1% | 75 | 5.7% |
血液、骨髄 | C420-C421 | 103 | 3.4% | 58 | 3.4% | 45 | 3.4% |
乳房 | C50 | 245 | 8.1% | 2 | 0.1% | 243 | 18.6% |
子宮 | C53-C55 | 178 | 5.9% | - | - | 178 | 13.6% |
( 子宮頚 ) | C53 | 92 | 3.0% | - | - | 92 | 7.0% |
( 子宮体部 ) | C54 | 85 | 2.8% | - | - | 85 | 6.5% |
( 子宮NOS ) | C55 | 1 | 0.0% | - | - | 1 | 0.1% |
前立腺 | C61 | 200 | 6.6% | 200 | 11.6% | - | - |
髄膜、脳、脊髄、脳神経及びその他の中枢神経系 | C70-C72 | 131 | 4.3% | 73 | 4.2% | 58 | 4.4% |
悪性リンパ腫 | M959-M972 | 161 | 5.3% | 85 | 4.9% | 76 | 5.8% |
その他(100件未満) | 739 | 24.3% | 418 | 24.2% | 321 | 24.6% |
※4 登録症例が年間100例に満たないものはその他に含みます。
Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|
手術または内視鏡的治療の割合 | 97.0% | 100.0% | 71.4% | 16.7% | 0.0% | 0.0% | 86.3% |
手術 | 26.5% | 100.0% | 71.4% | 16.7% | 0.0% | 0.0% | 28.1% |
(うち、体腔鏡的治療) | 15.2% | 50.0% | 0.0% | 0.0% | 0.0% | 0.0% | 13.1% |
内視鏡的治療 | 72.7% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 60.0% |
化学療法 | 2.3% | 50.0% | 71.4% | 77.8% | 0.0% | 0.0% | 14.4% |
(重複あり)
0期 | Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|---|
手術または内視鏡的治療の割合 | 100.0% | 100.0% | 92.3% | 81.8% | 62.5% | 100.0% | 0.0% | 88.7% |
手術 | 0.0% | 72.0% | 92.3% | 81.8% | 62.5% | 66.7% | 0.0% | 54.7% |
(うち、体腔鏡的治療) | 0.0% | 56.0% | 38.5% | 36.4% | 12.5% | 0.0% | 0.0% | 24.5% |
内視鏡的治療 | 100.0% | 28.0% | 0.0% | 0.0% | 0.0% | 33.3% | 0.0% | 34.0% |
放射線療法 | 0.0% | 0.0% | 0.0% | 9.1% | 0.0% | 0.0% | 0.0% | 0.9% |
化学療法 | 0.0% | 4.0% | 15.4% | 45.5% | 62.5% | 50.0% | 0.0% | 24.5% |
(重複あり)
Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|
手術または内視鏡的治療の割合 | 66.7% | 66.7% | 61.5% | 20.0% | 0.0% | 0.0% | 61.1% |
手術 | 66.7% | 66.7% | 61.5% | 20.0% | 0.0% | 0.0% | 61.1% |
(うち、体腔鏡的治療) | 4.2% | 0.0% | 0.0% | 20.0% | 0.0% | 0.0% | 1.9% |
内視鏡的治療 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
放射線療法 | 0.0% | 0.0% | 7.7% | 0.0% | 0.0% | 0.0% | 1.9% |
化学療法 | 20.8% | 41.7% | 23.1% | 80.0% | 0.0% | 0.0% | 31.5% |
TAE | 20.8% | 33.3% | 30.8% | 0.0% | 0.0% | 0.0% | 24.1% |
レーザー等治療 | 16.7% | 8.3% | 7.7% | 0.0% | 0.0% | 0.0% | 11.1% |
(重複あり)
Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|
手術または内視鏡的治療の割合 | 81.3% | 72.7% | 6.5% | 5.6% | 0.0% | 100.0% | 38.1% |
手術 | 81.3% | 72.7% | 6.5% | 7.4% | 0.0% | 100.0% | 38.6% |
(うち、体腔鏡的治療) | 73.4% | 54.5% | 4.3% | 1.9% | 0.0% | 100.0% | 32.4% |
内視鏡的治療 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
放射線療法 | 14.1% | 18.2% | 58.7% | 48.1% | 0.0% | 0.0% | 36.4% |
化学療法 | 7.8% | 54.5% | 60.9% | 77.8% | 0.0% | 0.0% | 46.0% |
レーザー等治療 | 3.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 1.1% |
その他 | 0.0% | 0.0% | 2.2% | 0.0% | 0.0% | 0.0% | 0.6% |
(重複あり)
0期 | Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|---|
手術の割合 | 100.0% | 95.9% | 96.2% | 81.8% | 0.0% | 0.0% | 0.0% | 84.3% |
放射線療法 | 76.2% | 34.7% | 34.6% | 36.4% | 35.7% | 0.0% | 0.0% | 42.1% |
化学療法 | 19.0% | 22.4% | 80.8% | 90.9% | 92.9% | 0.0% | 0.0% | 48.8% |
内分泌療法 | 61.9% | 83.7% | 65.4% | 36.4% | 14.3% | 0.0% | 0.0% | 63.6% |
(重複あり)